Sartorius Stedim Biotech (XPAR:DIM) Other Long-Term Liabilities : €496 Mil (As of Dec. 2023)

View and export this data going back to 1994. Start your Free Trial

What is Sartorius Stedim Biotech Other Long-Term Liabilities?

Sartorius Stedim Biotech's other long-term liabilities for the quarter that ended in Dec. 2023 was €496 Mil.

Sartorius Stedim Biotech's quarterly other long-term liabilities increased from Jun. 2023 (€300 Mil) to Sep. 2023 (€685 Mil) but then declined from Sep. 2023 (€685 Mil) to Dec. 2023 (€496 Mil).

Sartorius Stedim Biotech's annual other long-term liabilities declined from Dec. 2021 (€552 Mil) to Dec. 2022 (€372 Mil) but then increased from Dec. 2022 (€372 Mil) to Dec. 2023 (€496 Mil).

Sartorius Stedim Biotech Other Long-Term Liabilities Historical Data

The historical data trend for Sartorius Stedim Biotech's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius Stedim Biotech Other Long-Term Liabilities Chart

Sartorius Stedim Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Get a 7-Day Free Trial

Sartorius Stedim Biotech Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Sartorius Stedim Biotech Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Sartorius Stedim Biotech Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Sartorius Stedim Biotech's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Sartorius Stedim Biotech (XPAR:DIM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius Stedim Biotech SA (XPAR:DIM) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

SRTOY:USA SDMHF:USA DIM:Mexico DIMp:UK 0RG8:UK 56S1:Germany

Address

Otto-Brenner-Strasse 20, Goettingen, DEU, 37079

Website

https://www.sartorius.com

Sartorius Stedim Biotech, or SSB, is a leading provider of bioprocessing solutions. Its sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs, and has a focus on single-use technology, or SUT. It is a subsidiary of Sartorius AG, which has a 74% ownership and 85% voting control. The business is geographically diverse.